Načítá se...

Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity

OBJECTIVE: This study assessed the effects of 32 mg naltrexone sustained release (SR)/360 mg bupropion SR (NB) on body weight in adults with obesity, with comprehensive lifestyle intervention (CLI), for 78 weeks. METHODS: In this phase 3b, randomized, open‐label, controlled study, subjects received...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Obesity (Silver Spring)
Hlavní autoři: Halseth, Amy, Shan, Kevin, Walsh, Brandon, Gilder, Kye, Fujioka, Ken
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299461/
https://ncbi.nlm.nih.gov/pubmed/28026920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.21726
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!